LifeMD Analyst Price Targets - Benzinga

LifeMD Inc

LFMDNASDAQ

Trade with Public

Trade with Public

$2.25

-0.09-3.85%

Últ. Act.: Oct 19, 4:00 PM

$2.27

-0.07-2.99%

Panorámica general Noticias Previsión de beneficios EventosPrecios objetivoFinanzas Sentimiento Propiedad Comparar Opciones Informe de acciones

© 2026 Benzinga | All Rights Reserved

LifeMD Analyst Price Targets

Wall Street analyst price targets and consensus rating for LifeMD (LFMD).

Price Target Range — 12 Quarters

Analyst Consensus — 9 Analysts

9Buy

Consensus RatingBuy# Analysts9Avg. Consensus PT$10Upside to Avg. PT+340.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 17, 2026	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$9
Aug 7, 2026	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$10→$9
Aug 6, 2026	B. Riley Securities	William Woods	PT Cut	Buy	$10→$8
Aug 6, 2026	BTIG	David Larsen	PT Cut	Buy	$10→$9
May 26, 2026	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$10
May 4, 2026	BTIG	David Larsen	Maintained	Buy	$10
Mar 16, 2026	Mizuho	Steven Valiquette	Upgrade	Neutral→Outperform	$6→$8
Mar 12, 2026	Freedom Broker	Ilya Zubkov	PT Raise	Buy	$8→$10
Mar 11, 2026	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$9→$10
Mar 10, 2026	BTIG	David Larsen	Maintained	Buy	$10
Nov 24, 2025	Freedom Broker	Ilya Zubkov	PT Cut	Buy	$11→$8
Nov 19, 2025	Keybanc	Scott Schoenhaus	PT Cut	Overweight	$12→$8
Nov 19, 2025	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$13→$9
Nov 19, 2025	Mizuho	Steven Valiquette	PT Cut	Neutral	$8→$6
Nov 18, 2025	Lake Street	Brooks O'Neil	PT Cut	Buy	$14→$8
Nov 18, 2025	B. Riley Securities	William Woods	PT Cut	Buy	$12→$10
Nov 18, 2025	BTIG	David Larsen	PT Cut	Buy	$18→$10
Aug 7, 2025	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$14→$13
Aug 6, 2025	Freedom Broker	Ilya Zubkov	PT Cut	Buy	$13→$11
Aug 6, 2025	Lake Street	Brooks O'Neil	PT Cut	Buy	$18→$14

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on LifeMD, Maintains $9 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates LifeMD (NASDAQ:LFMD) with a Buy and maintains $9 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on LifeMD, Lowers Price Target to $9

HC Wainwright & Co. analyst Yi Chen maintains LifeMD (NASDAQ:LFMD) with a Buy and lowers the price target from $10 to $9.

Benzinga Newsdesk

PRO
B. Riley Securities Maintains Buy on LifeMD, Lowers Price Target to $8

B. Riley Securities analyst William Woods maintains LifeMD (NASDAQ:LFMD) with a Buy and lowers the price target from $10 to $8.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on LifeMD, Lowers Price Target to $9

BTIG analyst David Larsen maintains LifeMD (NASDAQ:LFMD) with a Buy and lowers the price target from $10 to $9.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on LifeMD, Maintains $10 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates LifeMD (NASDAQ:LFMD) with a Buy and maintains $10 price target.

Benzinga Newsdesk

PRO
BTIG Reiterates Buy on LifeMD, Maintains $10 Price Target

BTIG analyst David Larsen reiterates LifeMD (NASDAQ:LFMD) with a Buy and maintains $10 price target.

Benzinga Newsdesk